SCHEMBL10000684

SCHEMBL10000684

Oc1ccc(-c2ccc(-c3ccc(OCc4ccccc4)cc3)c(F)c2F)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.69
CYP1A2 P05177 1/20 0.69
PTGS1 P23219 1/20 0.69
SLC6A2 P23975 1/20 0.69
CYP2C19 P33261 1/20 0.69
PTGS2 P35354 1/20 0.69
SLC6A3 Q01959 1/20 0.69
HIF1A Q16665 1/20 0.69
HDAC6 Q9UBN7 1/20 0.69
GSTP1 P09211 2/20 0.58
GAA P10253 6/20 0.53
MGAM O43451 3/20 0.53
SI P14410 3/20 0.53
MGAM2 Q2M2H8 3/20 0.53
MAPT P10636 4/20 0.52
MEN1 O00255 2/20 0.52
BLM P54132 2/20 0.52
KMT2A Q03164 2/20 0.52
TP53 P04637 1/20 0.52
ATM Q13315 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8616558 0.86 GSTP1 (0.56) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL17495575 0.85 LMNA (0.61) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL8612967 0.85 GSTP1 (0.55) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL254671 0.85 LMNA (0.88) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL1461960 0.84 GSTP1 (0.51) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL8614632 0.84 GSTP1 (0.54) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL8613858 0.84 GSTP1 (0.54) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL8611289 0.84 GSTP1 (0.54) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL6059234 0.83 LMNA (0.85) LMNACYP1A2PTGS1SLC6A2CYP2C19
Monobenzone SCHEMBL8450838 0.83 LMNA (1.00) LMNACYP1A2PTGS1SLC6A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101095-B2 Antiferroelectric orthoconic liquid crystalline material with long pitch and the method of its preparation WOJSKOWA AKADEMIA TECHNICZNA IM. JAROSLAWA DABROWSKIEGO (PL) 2012-01-24 US disclosed
US-20100258765-A1 ANTIFERROELECTRIC ORTHOCONIC LIQUID CRYSTALLINE MATERIAL WITH LONG PITCH AND THE METHOD OF ITS PREPARATION WOJSKOWA AKADEMIA TECHNICZNA IM. JAROSLAWA DABROWSKIEGO (PL) 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100258765-A1 ANTIFERROELECTRIC ORTHOCONIC LIQUID CRYSTALLINE MATERIAL WITH LONG PITCH AND THE METHOD OF ITS PREPARATION CRY2, PAX2, CXXC5 LMNA 936/4885CYP1A2 2911/4885PTGS1 3952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.